State Street Portfolio holdings
State Street Corporation, established in 1792 and headquartered in Boston, Massachusetts, is one of the oldest financial institutions in the United States and a major player in the global asset management and custody banking sectors. Primarily known for its custodial services, it safeguards assets for institutional investors, managing trillions of dollars through its State Street Global Advisors (SSGA) division, which is renowned for launching the first U.S. exchange-traded fund (ETF), the SPDR S&P 500 ETF (SPY), in 1993. The company provides a range of services including investment management, research, trading, and data analytics, catering mostly to institutional clients like pension funds, endowments, and mutual funds. With a focus on financial infrastructure and innovation, State Street has positioned itself as a key backbone in the global investment ecosystem.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Blackstone
BX
|
+$692M |
| 2 |
Microsoft
MSFT
|
+$572M |
| 3 |
Palantir
PLTR
|
+$455M |
| 4 |
Equinix
EQIX
|
+$394M |
| 5 |
Vanguard FTSE Europe ETF
VGK
|
+$388M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$6.29B |
| 2 |
Carrier Global
CARR
|
+$945M |
| 3 |
Otis Worldwide
OTIS
|
+$809M |
| 4 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$665M |
| 5 |
TCF
TCF Financial Corporation Common Stock
TCF
|
+$314M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.66% |
| 2 | Financials | 14.6% |
| 3 | Healthcare | 13.07% |
| 4 | Consumer Discretionary | 11.08% |
| 5 | Industrials | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AIV
1926
Aimco
AIV
$383M
| $43.6M | ﹤0.01% |
6,494,637
+1,054,072
| +19% | +$7.25M |
|
1927
Surgery Partners
SGRY
$2.03B
| $43.5M | ﹤0.01% |
652,698
+107,565
| +20% | +$5.84M |
|
1928
NETGEAR
NTGR
$635M
| $43.4M | ﹤0.01% |
1,132,155
+13,088
| +1% | +$508K |
|
1929
Kadant
KAI
$3.99B
| $43.4M | ﹤0.01% |
246,310
+12,839
| +5% | +$2.26M |
|
1930
Axsome Therapeutics
AXSM
$10.9B
| $43.2M | ﹤0.01% |
639,757
+10,589
| +2% | +$635K |
|
1931
Verra Mobility
VRRM
$744M
| $43M | ﹤0.01% |
2,796,861
+148,700
| +6% | +$2.16M |
|
|
TPIC
1932
DELISTED
TPI Composites
TPIC
| $43M | ﹤0.01% |
887,074
-36,644
| -4% | -$1.8M |
|
|
HAPN
1933
Happen Inc
HAPN
$2.24B
| $42.9M | ﹤0.01% |
2,365,234
+709,886
| +43% | +$11M |
|
1934
Alto Ingredients
ALTO
$340M
| $42.9M | ﹤0.01% |
7,013,035
-2,399,371
| -25% | -$14M |
|
1935
Standex International
SXI
$4.12B
| $42.8M | ﹤0.01% |
451,399
+23,335
| +5% | +$2.26M |
|
1936
Clearway Energy Class C
CWEN
$6.7B
| $42.8M | ﹤0.01% |
1,616,391
+62,146
| +4% | +$1.71M |
|
1937
CorVel
CRVL
$3.19B
| $42.7M | ﹤0.01% |
953,985
+53,619
| +6% | +$2.12M |
|
1938
Rhythm Pharmaceuticals
RYTM
$7.96B
| $42.7M | ﹤0.01% |
2,179,087
-262,293
| -11% | -$5.45M |
|
1939
Towne Bank
TOWN
$3.42B
| $42.6M | ﹤0.01% |
1,390,571
+56,556
| +4% | +$1.77M |
|
|
RVNC
1940
DELISTED
Revance Therapeutics, Inc.
RVNC
| $42.6M | ﹤0.01% |
1,436,444
+85,278
| +6% | +$2.46M |
|
1941
British American Tobacco
BTI
$128B
| $42.5M | ﹤0.01% |
1,081,295
-298,293
| -22% | -$11.7M |
|
1942
LeMaitre Vascular
LMAT
$1.86B
| $42.5M | ﹤0.01% |
696,321
+17,001
| +3% | +$903K |
|
1943
Hyatt Hotels
H
$16.7B
| $42.5M | ﹤0.01% |
547,165
+118,944
| +28% | +$9.61M |
|
1944
Kopin
KOPN
$791M
| $42.5M | ﹤0.01% |
5,192,895
+2,878,070
| +124% | +$23.8M |
|
|
RDUS
1945
DELISTED
Radius Health, Inc.
RDUS
| $42.5M | ﹤0.01% |
2,327,416
+151,558
| +7% | +$3.01M |
|
1946
AdaptHealth
AHCO
$759M
| $42.4M | ﹤0.01% |
1,548,653
+260,215
| +20% | +$7.42M |
|
|
VBIV
1947
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $42.4M | ﹤0.01% |
421,977
-200,732
| -32% | -$19.6M |
|
1948
BioXcel Therapeutics
BTAI
$27.8M
| $42.4M | ﹤0.01% |
91,195
+11,451
| +14% | +$6.24M |
|
|
TWNK
1949
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
| $42.3M | ﹤0.01% |
2,615,271
+161,867
| +7% | +$2.52M |
|
|
GCP
1950
DELISTED
GCP Applied Technologies Inc.
GCP
| $42.3M | ﹤0.01% |
1,820,241
+576
| +0% | +$14.3K |
|
Similar funds
State Street's Q2 2021 Portfolio in Review
As of Q2 2021, State Street held 4,549 positions worth $1.9T, up 8.8% from $1.74T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
State Street's Q2 2021 filing shows 534 new, 2,776 increased, 937 reduced and 86 closed positions. Its largest new stake was Vanguard FTSE Europe ETF: 5,751,234 shares worth $387M. The largest sale was Alibaba, an estimated $6.29B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
- State Street's largest Q2 2021 buy was Vanguard FTSE Europe ETF: 5,751,234 shares worth $387M.
- State Street added most to Blackstone in Q2 2021, an estimated $692M increase.
- State Street's biggest Q2 2021 reduction was Alibaba, cutting an estimated $6.29B.
- State Street fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $665M.
- State Street's ten largest holdings make up 21% of its $1.9T portfolio in Q2 2021.
- State Street opened 534 new positions and closed 86 in Q2 2021.
- State Street's portfolio value rose 8.8% quarter-over-quarter to $1.9T.
Based on State Street's 13F filing for Q2 2021, filed 16 Aug 2021.